Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.

Laurent L, Lemaitre C, Minello A, Plessier A, Lamblin G, Poujol-Robert A, Gervais-Hasenknopf A, Pariente EA, Belenotti P, Mostefa-Kara N, Sogni P, Legrand M, Cournac JM, Tamion F, Savoye G, Bedossa P, Valla DC, Vilgrain V, Goria O.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1070-1076. doi: 10.1111/apt.14367. Epub 2017 Oct 11.

PMID:
29023905
2.

Adult onset Still's disease occurring during pregnancy: Case-report and literature review.

Plaçais L, Mekinian A, Bornes M, Poujol-Robert A, Bigé N, Maury E, Fain O.

Semin Arthritis Rheum. 2018 Feb;47(4):575-577. doi: 10.1016/j.semarthrit.2017.07.003. Epub 2017 Jul 10.

PMID:
28781105
3.

Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R; PARCOURS Study Group.

AIDS. 2016 Feb 20;30(4):645-56. doi: 10.1097/QAD.0000000000000957.

4.

Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.

Poujol-Robert A, Boëlle PY, Conti F, Durand F, Duvoux C, Wendum D, Paradis V, Mackiewicz V, Chazouillères O, Corpechot C, Poupon R.

Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):570-6. doi: 10.1016/j.clinre.2014.07.004. Epub 2014 Aug 15.

PMID:
25130796
5.

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.

Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E; ANRS HCEP 23 Fibrostar Group.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):467-72. doi: 10.1016/j.clinre.2013.07.003. Epub 2013 Aug 8.

PMID:
23932706
6.

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group.

Clin Chim Acta. 2013 Jan 16;415:63-8. doi: 10.1016/j.cca.2012.09.020. Epub 2012 Sep 27.

PMID:
23022619
7.

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.

Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP; ANRS HC EP 23 Fibrostar Study Group.

Clin Chem Lab Med. 2012 Jan 13;50(4):693-9. doi: 10.1515/cclm-2011-0858.

PMID:
22505560
8.

Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.

Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouillères O, Poupon R.

Hepatology. 2012 Jul;56(1):198-208. doi: 10.1002/hep.25599. Epub 2012 Jun 5.

PMID:
22271046
9.

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.

Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Le Naour G, Vaillant JC, Ratziu V, Charlotte F; Fibrosis-TAGS group.

J Hepatol. 2012 Mar;56(3):541-8. doi: 10.1016/j.jhep.2011.08.007. Epub 2011 Sep 1.

PMID:
21889468
10.

Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.

Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, Lasnier E, Poujol-Robert A, Ziegler F, Bourliere M, Voitot H, Larrey D, Rosenthal-Allieri MA, Fouchard Hubert I, Bailly F, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group.

J Hepatol. 2012 Jan;56(1):55-62. doi: 10.1016/j.jhep.2011.05.024. Epub 2011 Jul 23.

PMID:
21781944
11.

Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007.

Charles P, Lortholary O, Dechartres A, Doustdar F, Viard JP, Lecuit M, Gutierrez MC; French Mycobacterium genavense Study Group.

Medicine (Baltimore). 2011 Jul;90(4):223-30. doi: 10.1097/MD.0b013e318225ab89.

12.

Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort.

Guéchot J, Lasnier E, Sturm N, Paris A, Zarski JP; ANRS HC EP 23 Fibrostar study group.

Clin Chim Acta. 2010 Jan;411(1-2):86-91. doi: 10.1016/j.cca.2009.10.011. Epub 2009 Oct 19.

PMID:
19850017
13.

Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.

Serrate C, Silva-Moreno M, Dartigues P, Poujol-Robert A, Sokol H, Gorin NC, Coppo P.

Inflamm Bowel Dis. 2009 Oct;15(10):1449-51. doi: 10.1002/ibd.20823. No abstract available.

PMID:
19177429
14.

Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.

Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana JM, Poupon R.

Hepatology. 2007 Sep;46(3):658-65.

PMID:
17663420
15.

[Advances in clinical biology. Biological markers for assessment of liver fibrosis in chronic liver diseases].

Vaubourdolle M, Guéchot J; Marqueurs Biologiques de Fibrose Hépatique; Société Française de Biologie Clinique; Association Française pour l'Etude du Foie, Bartoli M, Boisson RC, Chevenne F, Gelineau MC, Guerber F, Lavoinne A, Maisonneuve L, Myara A, Poggi B, Poujol-Robert A, Renversez JC, Roudot-Thoraval F, Rosenthal-Allieri A, Vassault A, Zarski JP, Serge Zafrani E.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):603-7. French. No abstract available.

16.

Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.

Poujol-Robert A, Boëlle PY, Wendum D, Poupon R, Robert A.

Dig Dis Sci. 2006 Sep;51(9):1633-6. Epub 2006 Aug 22.

PMID:
16927132
17.

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouillères O, de Lédinghen V, Dhumeaux D, Marcellin P, Beaugrand M, Poupon R.

Hepatology. 2006 May;43(5):1118-24.

PMID:
16628644
18.

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.

Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L.

Gut. 2005 Jul;54(7):1003-8.

19.

Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.

Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R.

Liver Int. 2004 Jun;24(3):187-93.

PMID:
15189267
20.

Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

Poujol-Robert A, Boëlle PY, Poupon R, Robert A.

Hepatology. 2004 Apr;39(4):1174-5. No abstract available.

PMID:
15057924

Supplemental Content

Loading ...
Support Center